163 studies on IL-6 mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This study highlights MOTS-c as a crucial mediator of the cardioprotective effects of aerobic exercise in diabetic myocardial injury, primarily through enhancing antioxidant defense. The findings suggest that targetin…
This research strongly positions mitochondrial-derived peptides as a novel and potent class of therapeutic agents for the management of Type 2 Diabetes. Their ability to simultaneously improve insulin sensitivity, red…
This study identifies MOTS-c as a promising novel therapeutic agent for cancer-induced bone pain, addressing a significant unmet medical need in oncology. Its unique mechanism through AMPK-mediated mitochondrial bioge…
This groundbreaking research highlights MOTS-c as a highly promising novel therapeutic agent for the prevention and treatment of radiation pneumonitis. Its ability to simultaneously modulate inflammation, reduce oxida…
This study provides a robust mechanistic framework for understanding how MOTS-c protects the brain after traumatic injury, highlighting its role in enhancing mitochondrial function and reducing inflammation and oxidat…
The most significant finding was that MOTS-c administration achieved comparable or superior protective effects to remote ischemic preconditioning in mitigating lung ischemia-reperfusion injury, reducing tissue damage …
This research highlights MOTS-c as a promising novel therapeutic agent for preventing or treating CPB-induced acute lung injury. By promoting glycolysis through the AMPK-HIF-1α-PFKFB3 pathway, MOTS-c offers a unique m…
The findings underscore the significant therapeutic potential of mitochondrial-derived peptides as a novel class of agents for preventing and treating vascular aging and associated cardiovascular diseases. By targetin…
This research highlights MOTS-c as a promising therapeutic candidate for mitigating sepsis-associated brain injury by directly targeting the blood-brain barrier. The ability of MOTS-c to preserve BBB integrity and red…
This research highlights MOTS-c as a promising therapeutic candidate for preventing or treating acute liver injury caused by acetaminophen overdose. Its ability to modulate the MAPK signaling pathway and reduce both n…
This review significantly advances our understanding of the multifaceted nature of obesity, providing a robust framework for developing more effective and personalized treatments. The detailed exploration of molecular…
This research highlights the potent renoprotective capabilities of multi-agonist incretin therapies, particularly Retatrutide, in managing Diabetic Kidney Disease. The superior efficacy of Retatrutide, which targets G…
This groundbreaking research powerfully highlights the potential of Thymosin alpha 1 as a novel and effective therapeutic agent for addressing the complex systemic complications of cystic fibrosis, offering a much-nee…
This study provides crucial insights into the gender-specific immune dysregulation observed in COVID-19, highlighting lower T-cell counts and higher inflammation in males. The finding that males with severe disease al…
This study provides compelling evidence that thymosin α1 can significantly improve survival rates in critically ill COVID-19 patients, highlighting its potential as a crucial adjunctive therapy. The observed reduction…
This study provides compelling in vitro evidence that Thymosin Alpha 1 can effectively mitigate the cytokine storm observed in COVID-19 patients at a cellular level. The ability to dampen excessive inflammation withou…
These findings suggest that Thymosin Alpha 1 could serve as an effective early intervention for non-severe COVID-19, potentially preventing disease worsening and accelerating recovery. The significant reduction in pro…
This study provides compelling real-world evidence supporting the immunomodulatory benefits of Thymosin Alpha 1 in managing COVID-19, particularly in reducing mortality and disease severity. The observed improvements …
This study provides compelling evidence that combining Thymosin α1 with blood purification offers a promising new therapeutic strategy for managing severe shock, potentially leading to a significant reduction in patie…
This pilot study provides early evidence that immunomodulatory therapies like etanercept and alpha-1 antitrypsin could significantly enhance the success of autologous islet transplantation by reducing early inflammato…
This research provides compelling evidence that Thymosin α1 possesses significant immunomodulatory properties that could be highly beneficial in managing SARS-CoV-2 infection. By dampening the excessive inflammatory r…
This study provides compelling evidence that Thymosin alpha 1 can effectively restore critical aspects of immune homeostasis in patients suffering from Long COVID. The observed improvements in T cell subsets, reductio…
Thymosin α1 demonstrates potent immunomodulatory and antiviral effects, significantly improving survival and reducing viral load in a severe influenza model. Its ability to enhance both innate and adaptive immune resp…
The Thymalfasin treatment group demonstrated significantly faster clinical recovery compared to the control group. The median time to clinical discharge was 14 days for Thymalfasin patients, markedly shorter than the …
This meta-analysis provides compelling evidence supporting the beneficial role of Thymosin Alpha-1 as an adjunctive therapy for moderate to critical COVID-19 patients. Its immunomodulatory properties, which help resto…
This paper strongly suggests that Thymosin Alpha-1 (Ta1), with its broad and beneficial effects on the immune system, is an ideal molecule for phenotypic drug discovery, offering a promising avenue for treating comple…
This meta-analysis provides compelling evidence supporting the use of Thymosin Alpha 1 as an effective adjunctive therapy for managing acute exacerbations of COPD. The consistent improvements in hospital stay and recu…
This study provides compelling initial evidence that Thymosin alpha-1 may offer a novel and effective treatment strategy for depression in CVID patients, addressing both immune dysregulation and mood symptoms. The obs…
This umbrella review provides compelling evidence that Ulinastatin is a beneficial adjunctive therapy for sepsis, significantly improving patient survival and reducing organ dysfunction. The consistent findings across…
This comprehensive meta-analysis provides strong evidence that Thymosin alpha 1 (Tα1), an immunomodulatory peptide, can effectively reduce inflammation and prevent infections in patients with severe acute pancreatitis…
The findings suggest that topical copper tripeptide complex could significantly improve patient outcomes by accelerating recovery and reducing the downtime associated with CO2 laser resurfacing. This could lead to inc…
This comprehensive review unequivocally underscores GHK's significant potential as a versatile therapeutic agent for a wide range of conditions involving tissue damage, impaired regeneration, and pathological fibrosis…
This review underscores the GHK peptide's remarkable potential as a broad-spectrum therapeutic agent, capable of influencing fundamental cellular processes to combat aging and disease. By demonstrating its ability to …
This research highlights the superiority of microneedle technology in overcoming the skin barrier for large molecule delivery, particularly for therapeutic peptides like GHK-Cu. The ability to deliver GHK-Cu effective…
This review underscores the profound therapeutic potential of the GHK peptide as a natural, multi-target agent for skin regeneration and anti-aging. Its ability to simultaneously boost collagen, reduce inflammation, a…
These findings are highly significant as they demonstrate that GHK-Cu possesses a potent protective effect in LPS-induced acute lung injury by inhibiting excessive inflammatory responses and oxidative stress. This sug…
This study highlights the significant potential of copper peptide-functionalized biomimetic hydrogels to overcome the challenges of chronic diabetic wounds. By promoting angiogenesis, collagen synthesis, and reducing …
This study provides compelling and quantitative evidence for GHK-Cu's potent anti-inflammatory and skin regenerative properties, particularly highlighting its efficacy in mitigating the symptoms and underlying patholo…
The findings from this study are highly significant, as they demonstrate that GHK-Cu possesses potent anti-cachectic properties, effectively preserving muscle mass and improving muscle function in a preclinical model.…
These findings are highly significant as they demonstrate that GHK peptide can effectively combat age-related cognitive decline through a non-invasive delivery method. This suggests GHK peptide represents a promising …
This study provides compelling evidence that GHK-Cu possesses significant anti-inflammatory, tissue-repairing, and gut barrier-enhancing properties in an experimental model of colitis. These findings suggest its stron…
These compelling findings highlight BPC 157's significant therapeutic potential in treating severe gastrointestinal pathologies by promoting healing, reducing inflammation, and combating oxidative stress. Its ability …
This study provides compelling evidence for the potent regenerative and cytoprotective effects of BPC 157, particularly its ability to promote vascular recruitment and accelerate gastrointestinal healing. The observed…
This research highlights the significant therapeutic potential of BPC 157 for preventing or treating hepatic ischemia-reperfusion injury, a common and severe complication in liver surgery and transplantation. Given it…
These findings strongly underscore BPC 157's potent therapeutic potential in accelerating and improving the quality of wound healing. Its multifaceted action, including enhanced collagen synthesis, robust angiogenesis…
This study provides compelling preclinical evidence that BPC 157, administered directly into the joint, possesses broad regenerative and anti-inflammatory properties capable of addressing multiple forms of knee pain a…
This study highlights the significant therapeutic potential of BPC 157 in treating severe vascular occlusive diseases like SMAVO. The ability of BPC 157 to not only reduce tissue damage and inflammation but also to ac…
This extensive review underscores the significant therapeutic potential of BPC 157 for a wide range of central nervous system disorders, including traumatic brain injury, stroke, spinal cord injury, and potentially ne…
This study provides compelling evidence that BPC 157 possesses significant therapeutic potential for glaucoma, extending beyond mere intraocular pressure (IOP) reduction to include direct neuroprotection and potent an…